ILapatinib ePhakathi CAS 231278-84-5 Ubunyulu >98.0% (HPLC)

Inkcazelo emfutshane:

5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde

CAS: 231278-84-5

Ubunyulu: >98.0% (HPLC)

Imbonakalo: Mthubi oMthubi ukuya kuMthubi womgubo oqinileyo

I-API ephakathi (CAS 388082-77-7)

Qhagamshelana: UGqr. Alvin Huang

Iselula/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

AbaPhakathi beLapatinib:

Iipropati zeMichiza:

Igama leMchiza 5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde
Izithethantonye ILapatinib ePhakathi 3;5-[4-[[3-Chloro-4-[(3-Fluorophenyl)methoxy]phenyl]amino]-6-Quinazolinyl]-2-Furancarboxaldehyde;5-[4-((3-Chloro-4-((3-Fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-Furaldehyde
Inombolo yeCAS 231278-84-5
Ubume beStokhwe Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli I-C26H17ClFN3O3
Ubunzima beMolekyuli 473.90
Indawo yokunyibilika 225.0 ukuba 235.0℃
Ukuxinana 1.407±0.06 g/cm3
Refractive Index 1.694
I-COA kunye ne-MSDS Iyafumaneka
Imvelaphi Shanghai, China
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Umgubo oMthubi oMthubi ukuya kumthubi
Ubunyulu / Indlela yokuHlalutya >98.0% (HPLC)
Indawo yokunyibilika 225.0 ~ 235.0℃
Ilahleko ekomisweni <1.00%
Intsalela kwi-Ignition <0.50%
Ukungcola ngokupheleleyo <2.00%
Iintsimbi ezinzima (njenge Pb) <20ppm
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa I-API ephakathi (CAS 388082-77-7)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

1

FAQ:

www.ruifuchem.com

231278-84-5 - Isicelo:

5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde (CAS: 231278-84-5) iphakathi kwe-API (CAS 388082-77-7) ).(i-CAS 388082-77-7) lichiza elijolise kumdlavuza webele ophuhliswe yi-British GlaxoSmithKline Co. I-tyrosine kinase inhibitor enokuthintela ngokufanelekileyo umsebenzi we-tyrosine kinase we-epidermal growth factor receptors 1 kunye ne-2 (ErbB1, ErbB2).Inokwenza ngokukodwa ngeendlela ezahlukeneyo, iqinisekisa ukuba iiseli zomhlaza wamabele azikwazi ukufumana iimpawu zokukhula.Ivimbela i-intracellular EGFR (ErbB-1) kunye ne-HER2 (ErbB-2) iisayithi ze-ATP, ukukhusela i-tumor cell phosphorylation kunye nokusebenza, ukuthintela izibonakaliso eziphantsi kwe-homogeneity kunye ne-heterogeneity ye-EGFR (ErbB-1) kunye ne-HER2 (ErbB-1) ukuncipha.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi